X

Drug Profile

Research programme: neurometabolic disorders live biotherapeutics - Bloom Science

Alternative Names: Research programme: neurometabolic disorders bacterial biotherapeutics - Bloom Science

Latest Information Update: 20 Feb 2023

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Bloom Science
Class Bacteria; Neuroprotectants
Mechanism of Action Bacteria replacements; Gastrointestinal microbiome modulators

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No
New Molecular Entity No

Highest Development Phases

Research Metabolic disorders; Neurological disorders

Most Recent Events

13 Jan 2023 Early research in Metabolic disorders in USA (PO) on or before January 2022 (Bloom Science pipeline; January 2023)
13 Jan 2023 Early research in Neurological disorders in USA (PO) on or before January 2022 (Bloom Science pipeline; January 2023)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com